Random decisions in pharma pricing bad for India’s healthThe decision goes against the National Pharmaceutical Pricing Policy (NPPP) 2012, which was deliberated by a group of ministers and approve...
Government mulls bringing cancer, AIDS drugs under price controlNPPA is looking at bringing medicines used for treating diseases such as cancer, AIDS and malaria under the price control mechanism.
Life saving drugs' prices set to fall soonPrices of 348 medicines, including life saving drugs will be cheaper soon by up to 80 per cent as the new Drug Price Control Order has come...
Drug pricing policy: Government receives information from 400 drug makersThe drug price regulator has asked pharmaceutical companies to submit complete data related to essential medicines in order to fix the pric...
Government notifies new drug pricing policy"The National Pharmaceutical Pricing Policy (NPPP-2012) approved by the Cabinet on November 22, 2012 has been notified on December 7, 2012."
Government plans to replace DPCO with a new legislationAs per the new drugs policy, all strengths and dosages specified in the National List of Essential Medicines (NLEM) 2011 will be under pric...
Indian pharma market to grow at 15.3 pc CAGR by FY14The growth rate for the domestic Indian pharmaceutical market is set to rise over medium-term.
- GoM on drug pricing defers decision, next meet on Friday
GoM headed by Sharad Pawar tasked with the mandate to finalise the country's drug pricing policy heard the views of industry bodies stakeho...
A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcareThe debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies.
- GoM on drug pricing defers decision
- GoM on drug pricing to meet today
A panel of ministers will meet on Wednesday to discuss the formula to cap the retail prices of 348 essential drugs and their combinations.
- GoM may decide drug pricing policy on Wednesday
A panel of ministers will meet on Wednesday to decide the formula to cap the retail prices of 348 essential drugs and their combinations.
- National Pharma Pricing Policy may be dropped; DoP to continue with production cost-based model
"The thinking of the department, evolved after considering stakeholders’ feedback, is to drop the market-based pricing model and go for the...
- National Pharmaceuticals Pricing Policy may cost pharma firms Rs 3,000 crore:Industry
"The IPA estimates that domestic price reductions alone will result in aggregate loss of sales of nearly Rs 3,000 crore, to the industry," ...
- No time frame for National Pharmaceutical Pricing Policy: Srikant Kumar Jena
The government said no time frame can be given for implementation of NPPP as it is awaiting the response from the concerned ministries and ...
- 'No time frame can be given for implementation of NPPP, 2011'
Govt said no time frame can be given for implementation of draft NPPP, 2011 as it is awaiting the response from the concerned ministries an...
- New pharma pricing policy can lead to shortage of drugs: Sun Pharmaceuticals Industries
Sun Pharmaceuticals Industries today hit out at the proposed draft new pharma pricing policy, 2011 saying it could lead to shortage of drug...